Advertisement
Advertisement

VCRE

V

Vicore Pharma Holding AB - ADR

12.09
USD
Sponsored
-0.30
-2.46%
Jul 15, 11:17 UTC -4
Open

VCRE Earnings Reports

Positive Surprise Ratio

VCRE beat 1 of 1 last estimates.

100%

Next Report

Date of Next Report
Aug 21, 2026
Estimate for Q2 26 (Revenue/ EPS)
$546.72K
/
-$0.45
Implied change from Q1 26 (Revenue/ EPS)
-9.18%
/
+15.38%
Implied change from Q2 25 (Revenue/ EPS)
--
/
--

Vicore Pharma Holding AB - ADR earnings per share and revenue

On May 06, 2026, VCRE reported earnings of -0.39 USD per share (EPS) for Q1 26, beating the estimate of -0.48 USD, resulting in a 20.34% surprise. Revenue reached 602.00 thousand, compared to an expected 486.54 thousand, with a 23.73% difference.
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.45 USD, with revenue projected to reach 546.72 thousand USD, implying an increase of 15.38% EPS, and decrease of -9.18% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Bank of New York Mellon Corporation
Report Date
Jul 15, 2026 For Q2 26
Estimate
$2.24
Actual
$2.46
Surprise
+9.62%
FAQ
For Q1 2026, Vicore Pharma Holding AB - ADR reported EPS of -$0.39, beating estimates by 20.34%, and revenue of $602.00K, 23.73% above expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for Aug 21, 2026.
Based on -- analysts, Vicore Pharma Holding AB - ADR is expected to report EPS of -$0.45 and revenue of $546.72K for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement